We are live on
!
Find out more
BCPEM
Bain Capital Public Equity Management Portfolio holdings
AUM
$1.05B
1-Year Est. Return
25.71%
This Fund
S&P 500
This Quarter
Est. Return
+11.46%
1 Year Est. Return
+25.71%
3 Year Est. Return
+127.65%
5 Year Est. Return
+213.44%
10 Year Est. Return
–
AUM
$1.54B
AUM Growth
-$845M
(-35%)
Cap. Flow
-$1.01B
Cap. Flow
% of AUM
-65.67%
Top 10 Holdings %
Top 10 Hldgs %
66.18%
Holding
43
New
11
Increased
6
Reduced
11
Closed
12
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Merck
MRK
|
+$124M |
| 2 |
Fidelity National Information Services
FIS
|
+$79.2M |
| 3 |
AMSG
Amsurg Corp
AMSG
|
+$40.7M |
| 4 |
ARRS
ARRIS International plc Ordinary Shares
ARRS
|
+$25.4M |
| 5 |
Amdocs
DOX
|
+$21.9M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
TransDigm Group
TDG
|
+$161M |
| 2 |
MDVN
MEDIVATION, INC.
MDVN
|
+$112M |
| 3 |
Ball Corp
BALL
|
+$104M |
| 4 |
Newell Brands
NWL
|
+$99.8M |
| 5 |
MGM Resorts International
MGM
|
+$96.2M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 39.96% |
| 2 | Healthcare | 27.65% |
| 3 | Consumer Discretionary | 8.14% |
| 4 | Real Estate | 3.82% |
| 5 | Communication Services | 2.78% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
RDUS
1
DELISTED
Radius Health, Inc.
RDUS
| $129M | 8.36% |
2,383,198
-956,114
| -29% | -$48.6M |
|
|
2
Merck
MRK
$322B
| $127M | 8.21% |
+2,126,267
| New | +$124M |
|
|
AGN
3
DELISTED
Allergan plc
AGN
| $126M | 8.14% |
545,101
-308,575
| -36% | -$75.4M |
|
4
Sabre
SABR
$716M
| $118M | 7.62% |
4,169,897
+115,822
| +3% | +$3.23M |
|
5
Viasat
VSAT
$9.67B
| $116M | 7.53% |
1,554,634
+32,470
| +2% | +$2.4M |
|
|
DATA
6
DELISTED
Tableau Software, Inc.
DATA
| $108M | 7.02% |
1,958,953
-152,015
| -7% | -$8.37M |
|
|
CTXS
7
DELISTED
Citrix Systems Inc
CTXS
| $90.1M | 5.85% |
1,328,216
-774,336
| -37% | -$52.7M |
|
|
8
Fidelity National Information Services
FIS
$24.2B
| $78.1M | 5.06% |
+1,013,415
| New | +$79.2M |
|
|
9
MGM Resorts International
MGM
$11.7B
| $73.8M | 4.78% |
2,834,001
-3,963,800
| -58% | -$96.2M |
|
|
10
Amdocs
DOX
$6.03B
| $55.7M | 3.61% |
962,275
+372,010
| +63% | +$21.9M |
|
|
11
Ball Corp
BALL
$17.5B
| $51.7M | 3.35% |
1,261,776
-2,711,912
| -68% | -$104M |
|
12
IQVIA
IQV
$40.7B
| $49.6M | 3.21% |
611,557
| – | – |
|
|
ZAYO
13
DELISTED
Zayo Group Holdings, Inc.
ZAYO
| $47.5M | 3.08% |
1,597,209
-1,593,783
| -50% | -$46.1M |
|
|
CYBR
14
DELISTED
CyberArk
CYBR
| $43.3M | 2.81% |
873,959
+19,714
| +2% | +$1.05M |
|
15
Televisa
TV
$1.49B
| $42.9M | 2.78% |
1,671,626
+43,742
| +3% | +$1.15M |
|
|
AMSG
16
DELISTED
Amsurg Corp
AMSG
| $39.1M | 2.53% |
+582,671
| New | +$40.7M |
|
17
Avis
CAR
$5.47B
| $36.4M | 2.36% |
1,062,750
-1,391,488
| -57% | -$50.4M |
|
18
Regenxbio
RGNX
$616M
| $34.6M | 2.25% |
2,472,087
+543,320
| +28% | +$6M |
|
|
MGP
19
DELISTED
MGM Growth Properties LLC Class A common shares representing limited liability company interests
MGP
| $27.7M | 1.79% |
1,060,702
-139,298
| -12% | -$3.64M |
|
20
Teleflex
TFX
$5.96B
| $27M | 1.75% |
160,591
-535,322
| -77% | -$95.9M |
|
|
ARRS
21
DELISTED
ARRIS International plc Ordinary Shares
ARRS
| $26.9M | 1.74% |
+949,381
| New | +$25.4M |
|
|
ONCE
22
DELISTED
Spark Therapeutics, Inc. Common Stock
ONCE
| $22.1M | 1.43% |
367,314
-56,800
| -13% | -$3.27M |
|
23
Voyager Therapeutics
VYGR
$181M
| $18.2M | 1.18% |
1,514,082
| – | – |
|
24
SBA Communications
SBAC
$19.8B
| $15.9M | 1.03% |
+141,586
| New | +$16M |
|
25
Crown Castle
CCI
$34.6B
| $15.3M | 0.99% |
+162,434
| New | +$15.6M |
|
Similar funds
WF
DCM
AB
MFBTD
IAS
SA
TL
ACM
Bain Capital Public Equity Management's Q3 2016 Portfolio in Review
As of Q3 2016, Bain Capital Public Equity Management held 43 positions worth $1.54B, down 35% from $2.39B the previous quarter. Its ten largest holdings account for 66% of the portfolio.
Bain Capital Public Equity Management withdrew a net $1.01B in Q3 2016, closing 12 positions and reducing 11 holdings. Its most notable exit was TransDigm Group, an estimated $161M position sold in full.
By sector, the portfolio is most concentrated in Technology at 40% of assets, up from 27% a quarter earlier, followed by Healthcare and Consumer Discretionary.
Against the trend, Bain Capital Public Equity Management opened a new position in Merck worth $127M.
- Bain Capital Public Equity Management's largest Q3 2016 buy was Merck: 2,126,267 shares worth $127M.
- Bain Capital Public Equity Management added most to Amdocs in Q3 2016, an estimated $21.9M increase.
- Bain Capital Public Equity Management's biggest Q3 2016 reduction was Ball Corp, cutting an estimated $104M.
- Bain Capital Public Equity Management fully exited TransDigm Group in Q3 2016, selling an estimated $161M.
- Bain Capital Public Equity Management's ten largest holdings make up 66% of its $1.54B portfolio in Q3 2016.
- Bain Capital Public Equity Management opened 11 new positions and closed 12 in Q3 2016.
- Bain Capital Public Equity Management's portfolio value fell 35% quarter-over-quarter to $1.54B.
Based on Bain Capital Public Equity Management's 13F filing for Q3 2016, filed 14 Nov 2016.